Assessment of the Utilization of Sodium–Glucose Cotransporter-2 Inhibitors in Patients Without Diabetes

Assessment of the Utilization of Sodium–Glucose Cotransporter-2 Inhibitors in Patients Without Diabetes

Background: Sodium–glucose cotransporter-2 inhibitors (SGLT2Is) have demonstrated effects beyond glucose-lowering, leading to their approval for treating chronic heart failure (HF) in Japan. This study examines prescription trends for SGLT2Is in patients with diabetes versus those without diabetes,...

Full description

Saved in:
Bibliographic Details
Main Authors: Takuma Koinuma, Manato Yoshida, Manabu Akazawa
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmacoepidemiology
Subjects:
sodium–glucose cotransporter 2
heart failure
diabetes
non-diabetes
Online Access:https://www.mdpi.com/2813-0618/3/4/27
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items